apple fetured image
Banking & Finance News Stories

Global Response: Apple Invested $10M to COPAN Diagnostics

Apple invests $10 million to COPAN Diagnostics, a manufacturer of collection kits for coronavirus samples.

The investment is part of its Advanced Manufacturing Fund for US Business and will help the company grow production levels to more than one million kits per week.

In the past, Apple has used the Advanced Manufacturing Fund to invest in companies directly related to its supply chain. The investment is just one of the things Apple is doing to help fight the coronavirus pandemic.

The $10 million investment in COPAN joins tens of millions of dollars in other donations to causes like the American Food Fund.

Apple has also donated 20 million N95 masks and is designing and shipping face shields at a rate of about one million per week.

COPAN Diagnostics currently produces a few thousand kits per week. Apple says it is helping to design the equipment that COPAN Diagnostics will use to scale up its operations to more than one million units per week by early July.

According to Apple COO Jeff Williams, Apple is thrilled to partner with COPAN to help support the global response to COVID-9, “We feel a deep sense of responsibility to do everything we can to help medical workers, patients, and communities support the global response to COVID-19,” said Jeff Williams, Apple’s chief operating officer. “COPAN is one of the world’s most innovative manufacturers of sample collection kits for COVID-19 testing, and we’re thrilled to partner with them so they can expand as we work to address this critical issue for our nation. I couldn’t be prouder of our teams for bringing all of their energy, passion, and innovative spirit to supporting the country’s COVID-19 response.”